Circadian variations of infarct size in acute myocardial infarction

Heart

Volumn 97, Issue 12, 2011, Pages 970-976

  Suárez Barrientos, Aida ^a   López Romero, Pedro ^b   Vivas, David ^a,b   Castro Ferreira, Francisco ^a   Núñez Gil, Ivan ^a,b   Franco, Eduardo ^a   Ruiz Mateos, Borja ^a   García Rubira, Juan Carlos ^a   Fernández Ortiz, Antonio ^a   Macaya, Carlos ^a   Ibanez, Borja ^a,b  

^a HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; TROPONIN I;

ACUTE HEART INFARCTION; ADULT; ANTERIOR MYOCARDIAL INFARCTION; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART FAILURE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ANALYSIS OF VARIANCE; CIRCADIAN RHYTHM; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 79956312699     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.212621     Document Type: Article

References (36)

1. Rudic RD. Time is of the essence: vascular implications of the circadian clock. Circulation 2009;120:1714-21.
2. Muller JE, Tofler GH, Stone PH. Circadian variation and triggers of onset of acute cardiovascular disease. Circulation 1989;79:733-43. (Pubitemid 19100532)
3. Ohkura N, Oishi K, Sudo T, et al. CLOCK regulates circadian platelet activity. Thromb Res 2009;123:523-7.
4. Durgan DJ, Young ME. The cardiomyocyte circadian clock: emerging roles in health and disease. Circ Res 2010;106:647-58.
5. Hjalmarson A, Gilpin EA, Nicod P, et al. Differing circadian patterns of symptom onset in subgroups of patients with acute myocardial infarction. Circulation 1989;80:267-75. (Pubitemid 19195735)
6. Ridker PM, Manson JE, Buring JE, et al. Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians. Circulation 1990;82:897-902. (Pubitemid 20316741)
7. Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 2004;61:448-60. (Pubitemid 38210151)
8. Ibanez B, Fuster V, Jimenez-Borreguero J, et al. Lethal myocardial reperfusion injury: a necessary evil? Int J Cardiol Published Online First: 18 November 2010. doi:10.1016/j.ijcard.2010.10.056. PMID: 21093938.
9. Iitaka C, Miyazaki K, Akaike T, et al. A role for glycogen synthase kinase-3beta in the mammalian circadian clock. J Biol Chem 2005;280:29397-402. (Pubitemid 41177011)
10. Durgan DJ, Pulinilkunnil T, Villegas-Montoya C, et al. Short communication: ischemia/reperfusion tolerance is time-of-day-dependent: mediation by the cardiomyocyte circadian clock. Circ Res 2010;106:546-50.
11. Chia S, Senatore F, Raffel OC, et al. Utility of cardiac biomarkers in predicting infarct size, left ventricular function, and clinical outcome after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. JACC Cardiovasc Interv 2008;1:415-23.
12. Muller JE, Ludmer PL, Willich SN, et al. Circadian variation in the frequency of sudden cardiac death. Circulation 1987;75:131-8. (Pubitemid 17234550)
13. Muller JE, Stone PH, Turi ZG, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985;313:1315-22. (Pubitemid 16206020)
14. Willich SN, Linderer T, Wegscheider K, et al. Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. ISAM Study Group. Circulation 1989;80:853-8. (Pubitemid 19261632)
15. Richards AM, Nicholls MG, Espiner EA, et al. Diurnal patterns of blood pressure, heart rate and vasoactive hormones in normal man. Clin Exp Hypertens 1986;8:153-66. (Pubitemid 16078839)
16. Anon. Morning peak in the incidence of myocardial infarction: experience in the ISIS-2 trial. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Eur Heart J 1992;13:594-8.
17. Elliott WJ. Circadian variation in the timing of stroke onset: a meta-analysis. Stroke 1998;29:992-6. (Pubitemid 28228162)
18. Englund A, Behrens S, Wegscheider K, et al. Circadian variation of malignant ventricular arrhythmias in patients with ischemic and nonischemic heart disease after cardioverter defibrillator implantation. European 7219 Jewel Investigators. J Am Coll Cardiol 1999;34:1560-8. (Pubitemid 29528672)
19. Manfredini R, Boari B, Gallerani M, et al. Chronobiology of rupture and dissection of aortic aneurysms. J Vasc Surg 2004;40:382-8. (Pubitemid 39055909)
20. Kono T, Morita H, Nishina T, et al. Circadian variations of onset of acute myocardial infarction and efficacy of thrombolytic therapy. J Am Coll Cardiol 1996;27:774-8. (Pubitemid 26104855)
21. Cohen MC, Rohtla KM, Lavery CE, et al. Meta-analysis of the morning excess of acute myocardial infarction and sudden cardiac death. Am J Cardiol 1997;79:1512-16. (Pubitemid 27251072)
22. Gnecchi-Ruscone T, Piccaluga E, Guzzetti S, et al. Morning and Monday: critical periods for the onset of acute myocardial infarction. The GISSI 2 Study experience. Eur Heart J 1994;15:882-7.
23. Peters RW, Muller JE, Goldstein S, et al. Propranolol and the morning increase in the frequency of sudden cardiac death (BHAT Study). Am J Cardiol 1989;63:1518-20. (Pubitemid 19153805)
24. Ibanez B, Prat-Gonzalez S, Speidl WS, et al. Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance. Circulation 2007;115:2909-16. (Pubitemid 46915384)
25. Ibanez B, Cimmino G, Prat-Gonzalez S, et al. The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusion. Int J Cardiol. 2011;147:428-32.
26. Halkin A, Grines CL, Cox DA, et al. Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction. J Am Coll Cardiol 2004;43:1780-7. (Pubitemid 38622514)
27. Sharma SK, Kini A, Marmur JD, et al. Cardioprotective effect of prior beta-blocker therapy in reducing creatine kinase-MB elevation after coronary intervention: benefit is extended to improvement in intermediate-term survival. Circulation 2000;102:166-72. (Pubitemid 30451772)
28. Ibanez B, Cimmino G, Badimon JJ. Myocardial reperfusion injury. N Engl J Med 2007;357:2409-10.
29. Rana JS, Mukamal KJ, Morgan JP, et al. Circadian variation in the onset of myocardial infarction: effect of duration of diabetes. Diabetes 2003;52:1464-8. (Pubitemid 36666202)
30. Vivas D, Garcia-Rubira JC, Gonzalez-Ferrer JJ, et al. [Prognostic value of first fasting glucose measurement compared with admission glucose level in patients with acute coronary syndrome]. Rev Esp Cardiol 2008;61:458-64.
31. Zahn R, Schiele R, Seidl K, et al. Daytime and nighttime differences in patterns of performance of primary angioplasty in the treatment of patients with acute myocardial infarction. Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Study Group. Am Heart J 1999;138:1111-17.
32. De Luca G, Suryapranata H, Ottervanger JP, et al. Circadian variation in myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. Am Heart J 2005;150:1185-9. (Pubitemid 41773520)
33. Linsell CR, Lightman SL, Mullen PE, et al. Circadian rhythms of epinephrine and norepinephrine in man. J Clin Endocrinol Metab 1985;60:1210-15. (Pubitemid 15064783)
34. Tofler GH, Brezinski D, Schafer AI, et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987;316:1514-18. (Pubitemid 17076236)
35. Kelle S, Roes SD, Klein C, et al. Prognostic value of myocardial infarct size and contractile reserve using magnetic resonance imaging. J Am Coll Cardiol 2009;54:1770-7.
36. Mewton N, Croisille P, Gahide G, et al. Effect of cyclosporine on left ventricular remodeling after reperfused myocardial infarction. J Am Coll Cardiol 2010;55:1200-5.